Veeva Systems Pre-Tax Profit Margin 2012-2025 | VEEV
Current and historical pre-tax profit margin for Veeva Systems (VEEV) from 2012 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Veeva Systems pre-tax profit margin for the three months ending January 31, 2025 was .
| Veeva Systems Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2025-01-31 | $2.75B | $0.92B | 33.47% |
| 2024-10-31 | $2.66B | $0.86B | 32.27% |
| 2024-07-31 | $2.57B | $0.79B | 30.54% |
| 2024-04-30 | $2.49B | $0.70B | 28.30% |
| 2024-01-31 | $2.36B | $0.59B | 24.92% |
| 2023-10-31 | $2.30B | $0.54B | 23.56% |
| 2023-07-31 | $2.23B | $0.50B | 22.59% |
| 2023-04-30 | $2.18B | $0.47B | 21.61% |
| 2023-01-31 | $2.15B | $0.51B | 23.58% |
| 2022-10-31 | $2.08B | $0.49B | 23.70% |
| 2022-07-31 | $2.00B | $0.49B | 24.60% |
| 2022-04-30 | $1.92B | $0.51B | 26.48% |
| 2022-01-31 | $1.85B | $0.51B | 27.66% |
| 2021-10-31 | $1.76B | $0.50B | 28.25% |
| 2021-07-31 | $1.67B | $0.47B | 28.17% |
| 2021-04-30 | $1.56B | $0.44B | 27.90% |
| 2021-01-31 | $1.47B | $0.39B | 26.88% |
| 2020-10-31 | $1.38B | $0.35B | 25.63% |
| 2020-07-31 | $1.28B | $0.34B | 26.40% |
| 2020-04-30 | $1.20B | $0.33B | 27.32% |
| 2020-01-31 | $1.11B | $0.31B | 28.33% |
| 2019-10-31 | $1.03B | $0.32B | 30.93% |
| 2019-07-31 | $0.97B | $0.30B | 30.44% |
| 2019-04-30 | $0.91B | $0.27B | 29.61% |
| 2019-01-31 | $0.86B | $0.24B | 27.69% |
| 2018-10-31 | $0.82B | $0.21B | 25.95% |
| 2018-07-31 | $0.77B | $0.19B | 24.45% |
| 2018-04-30 | $0.73B | $0.17B | 23.80% |
| 2018-01-31 | $0.69B | $0.17B | 24.02% |
| 2017-10-31 | $0.66B | $0.17B | 25.53% |
| 2017-07-31 | $0.63B | $0.16B | 25.32% |
| 2017-04-30 | $0.59B | $0.14B | 23.69% |
| 2017-01-31 | $0.55B | $0.12B | 22.14% |
| 2016-10-31 | $0.51B | $0.09B | 18.11% |
| 2016-07-31 | $0.47B | $0.08B | 16.53% |
| 2016-04-30 | $0.44B | $0.08B | 17.77% |
| 2016-01-31 | $0.41B | $0.08B | 19.32% |
| 2015-10-31 | $0.38B | $0.08B | 21.73% |
| 2015-07-31 | $0.36B | $0.08B | 22.84% |
| 2015-04-30 | $0.34B | $0.08B | 22.85% |
| 2015-01-31 | $0.31B | $0.07B | 21.66% |
| 2014-10-31 | $0.29B | $0.06B | 20.69% |
| 2014-07-31 | $0.26B | $0.05B | 19.54% |
| 2014-04-30 | $0.24B | $0.04B | 18.72% |
| 2014-01-31 | $0.21B | $0.04B | 18.48% |
| 2013-07-31 | $0.13B | $0.03B | 20.93% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $35.134B | $2.747B |
| Veeva Systems Inc. offers cloud-based software applications and data solutions for the life sciences industry. The company's product portfolio includes Veeva CRM (customer relationship management), Veeva Vault (content and information management), Veeva Network (customer master and product data management) and Veeva data services (Veeva OpenData and Veeva KOL data). | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $6.966B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $6.050B | 97.25 |
| Inspire Medical Systems (INSP) | United States | $4.470B | 86.83 |
| IRhythm Technologies (IRTC) | United States | $3.223B | 0.00 |
| Privia Health (PRVA) | United States | $2.873B | 215.27 |
| Schrodinger (SDGR) | United States | $1.881B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.839B | 0.00 |
| Enovis (ENOV) | United States | $1.825B | 11.29 |
| Omnicell (OMCL) | United States | $1.418B | 30.59 |
| Phreesia (PHR) | United States | $1.409B | 0.00 |
| Azenta (AZTA) | United States | $1.154B | 53.72 |
| 10x Genomics (TXG) | United States | $0.918B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.568B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.551B | 0.00 |
| Talkspace (TALK) | United States | $0.450B | 267.00 |
| Veradigm (MDRX) | United States | $0.449B | 0.00 |
| Standard BioTools (LAB) | United States | $0.440B | 0.00 |
| TruBridge (TBRG) | United States | $0.363B | 0.00 |
| Claritev (CTEV) | United States | $0.325B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.270B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.206B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.189B | 0.00 |
| Pulmonx (LUNG) | United States | $0.182B | 0.00 |
| American Well (AMWL) | United States | $0.109B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.100B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.082B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.076B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.066B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| CareCloud (CCLD) | United States | $0.060B | 2.58 |
| HeartBeam (BEAT) | United States | $0.055B | 0.00 |
| Outset Medical (OM) | United States | $0.040B | 0.00 |
| Zepp Health (ZEPP) | China | $0.039B | 0.00 |
| Zhongchao (ZCMD) | China | $0.030B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Syra Health (SYRA) | United States | $0.001B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |